Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 4.6B | 4.2B | 4.1B | 3.9B |
Cost of revenue | 1.5B | 1.3B | 1.3B | 1.2B |
Gross profit | 3.1B | 2.9B | 2.9B | 2.6B |
Operating expense | ||||
Research & development | 459M | 407M | 383M | 366M |
Selling general and admin | 1.6B | 1.6B | 1.4B | 1.4B |
Other operating expenses | 9M | 5M | 9M | 10M |
Operating income | 790M | 718M | 799M | 693M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 80M | 79M | 77M | 69M |
Other income expense | -230M | 29M | -302M | -18M |
Pretax income | 585M | 669M | 420M | 608M |
Tax provision | 23M | 200M | 98M | 115M |
Net income | 562M | 468M | 322M | 493M |
Basic EPS | — | 0.3 | 0.2 | 0.3 |
Diluted EPS | — | 0.3 | 0.2 | 0.3 |
Basic average shares | — | 1.5B | 1.5B | 1.5B |
Diluted average shares | — | 1.5B | 1.5B | 1.5B |
EBITDA | 1.2B | 1.0B | 1.1B | 1.0B |
Net income from continuing op. | 562M | 469M | 322M | 493M |
Minority interests | 4M | 0 | 2M | -1M |
Preferred stock dividends | — | — | — | — |